Svoboda
|
Graniru
|
BBC Russia
|
Golosameriki
|
Facebook
Home
News
Tech
Finance
Leadership
Well
Recommends
Fortune 500
Home Page
Already have an account?
SIGN IN
SEARCH
Subscribe Now
Sections
FORTUNE 500
News
Europe
Asia
Tech
AI
Finance
Personal Finance
Real Estate
Crypto
Leadership
Success
Well
Life
Health
Mind
Family
Aging Well
Recommends
Credit Cards
Banking
Best High-Yield Savings Accounts
Best Savings Accounts
Best CD Rates
Best Money Market Accounts
Savings Calculator
Insurance
Mortgages
Investing
Loans
Health
Education
Top Business Schools
Top Information Technology and Data Schools
Top Health Schools
Coupons
Video
Rankings
FORTUNE 500
GLOBAL 500
MOST POWERFUL WOMEN
GREAT PLACE TO WORK LISTS
BEST MBA PROGRAMS
MORE RANKINGS
Analytics
Newsletters
Magazine
December 2023/January 2024
October/November 2023
August/September 2023
June/July 2023
April/May 2023
February/March 2023
Live Media
CEO Initiative
COVID-19 vaccines
Health
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
BY
Sunny Nagpaul
Health
COVID-19 hospitalizations hit record low
BY
Chris Morris
Health
A University of Oxford researcher is testing a revolutionary vaccine to prevent the onset of lung cancer
BY
Ryan Hogg
Politics
Supreme Court takes up dispute over how far government can go to combat controversial social media posts on topics like COVID-19 and election security
BY
Mark Sherman
and
The Associated Press
Health
U.S. health officials drop 5-day isolation time for COVID-19
BY
Mike Stobbe
and
The Associated Press
Health
Largest ever global study of COVID vaccines finds small but real link to neurological, blood, heart-related conditions
BY
Jason Gale
and
Bloomberg
Commentary
‘An age of manufactured mistrust’: Here’s what rampant disinformation means for health, climate, and democracy
BY
Bill Novelli
Commentary
‘On par with cancer and heart disease’: Experts, patients warn Congress about the burden of long COVID as the government blows through $1.15 billion without finding a cure
BY
Carolyn Barber
Health
New, highly mutated COVID variants ‘Pirola’ BA.2.86 and JN.1 may cause more severe disease, new studies suggest
BY
Erin Prater
Health
Highly mutated COVID variant ‘Pirola’ JN.1 is fueling the pandemic’s second highest U.S. wave—and it’s still growing
BY
Erin Prater
Health
‘Pirola’ JN.1 is the probable future of the COVID pandemic, experts warn—but you didn’t hear it from the WHO
BY
Erin Prater
Health
COVID-19 variant JN.1 symptoms: Is ‘Pirola’ different from other Omicron spawn?
BY
Erin Prater
Health
Santa’s super-spreader season: Health officials say flu, COVID set to spike during the holidays
BY
Mike Stobbe
and
The Associated Press
Health
JN.1, the WHO’s newest ‘variant of interest,’ has spiked COVID wastewater levels to all-time highs in some countries. What you need to know about the ‘Pirola’ offshoot
BY
Erin Prater
Health
U.S. states are trashing millions of COVID protective gear because of expiration, surpluses and a lack of willing takers: ‘That’s what happens when you don’t prepare’
BY
Jennifer Peltz
,
David A. Lieb
, and others
Load More
Most Popular
Finance
$3 trillion could be injected into the U.S. economy without any federal spending by tweaking this corner of the...
BY
Jason Ma
Finance
The U.S. economy is headed for a hard landing, and Fed rate cuts won’t be enough to rescue it, Citi says
BY
Jason Ma
Finance
Another Boeing whistleblower is dead—this time a healthy 45-year-old who battled a sudden, severe infection
BY
Will Daniel
